| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | CARA THERAPEUTICS INC | 622,140 | 10,489,000 | 45.13% | ||
| 2 | APPLIED GENETIC TECHNOL CORP | 246,005 | 5,019,000 | 21.59% | ||
| 3 | TRILLIUM THERAPEUTICS INC | 370,537 | 4,672,000 | 20.10% | ||
| 4 | OncoSec Medical Inc | 1,292,614 | 3,063,000 | 13.18% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000932440-16-000330, filed 2016.02.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
